Key Events This Week
1 June: Stock opens week at ₹374.15, down 1.68% amid broader market weakness
3 June: Intraday high of ₹405 reached with a 7.13% surge
4 June: Mixed technical signals emerge amid 6.8% price rally and valuation upgrade
5 June: Week closes at ₹395.55, up 3.94% for the week versus Sensex decline

Indraprastha Medical Corporation Ltd is Rated Sell
2026-06-14 10:10:29Indraprastha Medical Corporation Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Indraprastha Medical Corporation Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-06-11 08:00:07Indraprastha Medical Corporation Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the evolving price attractiveness of the hospital sector stock, comparing its key valuation metrics against historical averages and peer benchmarks to provide a comprehensive view for investors.
Read full news article
Indraprastha Medical Corporation Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
2026-06-04 08:00:15Indraprastha Medical Corporation Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, reflected in a recent upgrade from Hold to Sell by MarketsMOJO. Despite a strong intraday price surge of 6.80% to ₹402.15, the stock’s technical indicators present a complex picture, with a transition from bearish to mildly bearish trends and mixed signals across key metrics such as MACD, RSI, and moving averages.
Read full news article
Indraprastha Medical Corporation Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Comparisons
2026-06-04 08:00:06Indraprastha Medical Corporation Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change reflects evolving market perceptions and improved price metrics relative to its historical averages and peer group, signalling a potentially favourable entry point for investors amid a challenging hospital sector landscape.
Read full news article
Indraprastha Medical Corporation Ltd Surges 7.13% to Day's High of Rs 405 — Outperforms Sector by 5.8 Percentage Points
2026-06-03 15:01:05The Sensex declined 0.3% on 03 Jun 2026, while Indraprastha Medical Corporation Ltd surged 7.13%, marking a notable 5.8-percentage-point outperformance over its Hospital sector peers. This sharp intraday advance rewrites the short-term narrative for the stock, which has been steadily gaining over the past two sessions.
Read full news article
Indraprastha Medical Corporation Ltd is Rated Sell
2026-06-03 10:11:05Indraprastha Medical Corporation Ltd is rated Sell by MarketsMOJO. This rating was last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article







